Trials / Recruiting
RecruitingNCT06280677
Aurora Test for ART Donor Patients (AURORA-Donor)
An Observational Study to Evaluate the Expression Profiles of Oocyte-potency-related Genes in Cumulus Cells of Women Treated With Human Recombinant FSH (Hr-FSH)and Triggered With GnRH Agonist in an Oocyte Donation Program
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 160 (estimated)
- Sponsor
- Fertiga, Belgium · Industry
- Sex
- Female
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
This is a randomized observational study. The main aim is to determine potential oocyte competence predictive mRNA expression profiles in the cumulus cells isolated form individual oocytes. In 2 patient cohorts: 1)GnRH Antagonist \& hr-FSH with GnRH Agonist trigger, 2) Progesterone \& hr-FSH with GnRH Agonist trigger.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | AURORA-Donor | Explorative study of cumulus cells gene expression in relation to the oocyte competence for good quality blastocyst formation and predictive for clinical pregnancy. |
Timeline
- Start date
- 2024-02-16
- Primary completion
- 2026-04-01
- Completion
- 2026-09-01
- First posted
- 2024-02-28
- Last updated
- 2025-08-11
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT06280677. Inclusion in this directory is not an endorsement.